Shoshana Shendelman Ph.D.
Net Worth

Last updated:

What is Shoshana Shendelman Ph.D. net worth?

The estimated net worth of Dr. Shoshana Shendelman Ph.D. is at least $22,712,203 as of 14 Aug 2024. He owns shares worth $2,316,336 as insider, has earned $15,025,147 from insider trading and has received compensation worth at least $5,370,720 in Applied Therapeutics, Inc..

What is the salary of Shoshana Shendelman Ph.D.?

Dr. Shoshana Shendelman Ph.D. salary is $895,120 per year as Chair of the Board of Directors, Founder, Pres, Chief Executive Officer & Sec. in Applied Therapeutics, Inc..

How old is Shoshana Shendelman Ph.D.?

Dr. Shoshana Shendelman Ph.D. is 46 years old, born in 1979.

What stocks does Shoshana Shendelman Ph.D. currently own?

As insider, Dr. Shoshana Shendelman Ph.D. owns shares in one company:

Company Title Shares Price per share Total value
Applied Therapeutics, Inc. (APLT) Chair of the Board of Directors, Founder, Pres, Chief Executive Officer & Sec. 4,690,839 $0.49 $2,316,336

What does Applied Therapeutics, Inc. do?

Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study for the treatment of galactosemia in kids; for treating sorbitol dehydrogenase deficiency; and for the treatment of phosphomannomutase enzyme-CDG. The company also develops AT-001 that is in phase III clinical trials for treating diabetic cardiomyopathy, as well as for the treatment of diabetic peripheral neuropathy. Its preclinical stage products include AT-003 for the treatment diabetic retinopathy; AT-104, a PI3K inhibitor for treating orphan hematological oncology T Cell Acute Lymphoblastic Leukemia. Applied Therapeutics, Inc. was incorporated in 2016 and is headquartered in New York, New York.

APLT logo
APLT
Applied Therapeutics, Inc.
$0.49

Shoshana Shendelman Ph.D. insider trading

Applied Therapeutics, Inc.

Dr. Shoshana Shendelman Ph.D. has made 15 insider trades between 2019-2024, according to the Form 4 filled with the SEC. Most recently he sold 119,591 units of APLT stock worth $709,175 on 14 Aug 2024.

The largest trade he's ever made was exercising 357,423 units of APLT stock on 13 Aug 2024. As of 14 Aug 2024 he still owns at least 4,690,839 units of APLT stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 119,591 $5.93 $709,175
Sale
Common Stock 357,423 $6.18 $2,208,874
Sale
Common Stock 300,000 $5.98 $1,794,000
Sale
Common Stock 61,795 $4.32 $266,954
Sale
Common Stock 318,573 $5.39 $1,717,108
Sale
Common Stock 3,968 $1.97 $7,817
Sale
Common Stock 115,632 $2.7 $312,206
Sale
Common Stock 15,870 $0.91 $14,442
Purchase
Common Stock 50,000 $0.65 $32,250
Purchase
Common Stock 73,256 $0.56 $40,877
Purchase
Common Stock 38,153 $0.52 $19,954
Purchase
Common Stock 9,300 $14.49 $134,738
Purchase
Common Stock 701 $14.69 $10,298
Option
Common Stock 15,000 $1.44 $21,600
Option
Stock Option (Right to Buy) 15,000 $1.44 $21,600
Sale
Common Stock 15,000 $25.98 $389,700
Sale
Common Stock 15,000 $27.45 $411,750
Option
Stock Option (Right to Buy) 15,000 $1.44 $21,600
Option
Common Stock 15,000 $1.44 $21,600
Sale
Common Stock 15,000 $27.9 $418,545
Option
Common Stock 15,000 $1.44 $21,600
Option
Stock Option (Right to Buy) 15,000 $1.44 $21,600
Sale
Common Stock 15,000 $31.27 $469,050
Option
Stock Option (Right to Buy) 15,000 $1.44 $21,600
Option
Common Stock 15,000 $1.44 $21,600
Sale
Common Stock 15,000 $32.6 $488,925
Option
Stock Option (Right to Buy) 15,000 $1.44 $21,600
Option
Common Stock 15,000 $1.44 $21,600
Sale
Common Stock 15,000 $31.94 $479,100
Option
Common Stock 15,000 $1.44 $21,600
Option
Stock Option (Right to Buy) 15,000 $1.44 $21,600
Option
Common Stock 125,000 $1.22 $152,500
Option
Stock Option (Right to Buy) 125,000 $1.22 $152,500
Sale
Common Stock 125,000 $42.7 $5,337,500
Purchase
Common Stock 125,000 $10 $1,250,000

Applied Therapeutics key executives

Applied Therapeutics, Inc. executives and other stock owners filed with the SEC: